drugset / Trial / NCT05742724
The Pharmacokinetics of Single Dose Oral Tetrahydrocannabinol and Cannabidiol
Phase 1
Active not recruiting
24 enrolled
McMaster University
Center for Medicinal Cannabis Research · collab
NaSingle-groupOpen-labelOther
Summary
POT-GFR-PK is a single dose pharmacokinetic study oral tetrahydrocannabinol (THC) and cannabidiol (CBD) in healthy adult controls and individuals with chronic kidney disease including those treated with in-center hemodialysis.
Timeline
- Start
- 2024-01-11
- Primary completion
- 2024-02-16
- Completion
- 2025-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabidiol | Other / unclassified | 2.5 mg/kg | Oral |
| Subject | Dronabinol | Other / unclassified | 0.1 mg/kg | Oral |